Efficient enantioselective syntheses of chloramphenicol and (D)-threo- and (D)-erythro-sphingosine

Tetrahedron Letters

Volumn 41, Issue 16, 2000, Pages 2765-2768

  Corey, E J ^a   Choi, Soongyu ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; SPHINGOSINE DERIVATIVE;

ARTICLE; CHIRALITY; DRUG SYNTHESIS; STEREOISOMERISM; UNITED STATES;

EID: 0034655861     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(00)00301-4     Document Type: Article

References (38)

1. (a) Nakanishi, K.; Goto, T.; Ito, S.; Natoro, S.; Nozoe, S., Natural Products Chemistry; Oxford University Press: Oxford, 1983; Vol. 3.
2. (b) Fuganti, G.; Grasselli, P.; Pedrocchi-Fantoni, G. J. Org. Chem. 1983, 48, 909.
3. (c) Garner, P.; Ramkanth, S. J. Org. Chem. 1986, 51, 2609.
4. (d) Boutin, R. H.; Rapoport, H. J. Org. Chem. 1986, 51, 5320.
5. (e) Jacobsen, S. Acta Chem. Scand. 1988, B42, 605.
6. (a) Groth, U.; Schöllkopf, U.; Tiller, T. Tetrahedron 1991, 47, 2835 and references cited therein.
7. (b) Merck Index; 10th ed.; Merck and Co.: Rahway, NJ, 1983; p. 289.
8. (c) Bennet, R. B.; Choi, J. R.; Montgomery, W. D.; Cha, J. K. J. Am. Chem. Soc. 1989, 111, 2580.
9. (a) Beardsley, D. A.; Fisher, G. B.; Goralski, C. T.; Nicholson, L. W.; Singaram, B. Tetrahedron Lett. 1994, 35, 1511.
10. (b) Moody, M. H.; Kaptein, B.; Broxterman, Q. B.; Boesten, W. H. J.; Kamphuis, J. Tetrahedron Lett. 1994, 35, 1777.
11. (c) Sasai, H.; Kim, W.; Suzuki, T.; Shibasaki, M. Tetrahedron Lett. 1994, 35, 6123.
12. Corey, E. J.; Choi, S. Tetrahedron Lett. 1991, 32, 2857.
13. 2H, THF) followed by alkaline hydrolysis (2N KOH, EtOH, reflux). See: (a) Ito, Y.; Sawamura, M.; Hayahsi, T. Tetrahedron Lett. 1988, 29, 239.
14. (b) Herold, P. Helv. Chim. Acta 1988, 71, 354.
15. (a) Chloramphenicol has been assigned as a generic name to the compound D-(-)-threo-N-(1,1′-dihydroxy-1-p-nitrophenylisopropyl)-dichloroacetamide for which Parke, Davis and Co. has adopted 'Chloromycetin' as its trademark.
16. (b) Bartz, Q. R. J. Biol. Chem. 1948, 172, 445.
17. (a) Controulis, J.; Rebstock, M. C.; Crooks Jr., H. M. J. Am. Chem. Soc. 1949, 71, 2463.
18. (b) Rao, A. V. R. et al. J. Chem. Soc., Chem. Commun. 1992, 11, 859.
19. (c) Hazra, B. G. et al. Syn. Comm. 1997, 27(11), 1857.
20. (a) The absolute configuration was assumed from the results in Ref. 4 and confirmed later by comparison of the optical rotation with that reported for chloramphenicol (2).
21. (b) The enantiomeric purity (ee) was determined by HPLC analysis using a Daicel Chiralcel OJ column.
22. 3 solution.
23. Keeping the reaction mixture at 40°C was crucial for good yields of the azide 6.
24. Lambert, P. H.; Vaultier, M.; Carrie, R. J. Chem. Soc., Chem. Commun. 1982, 1224.
25. Dolbier Jr., W. R.; Lee, S. K.; Phanstiel IV., O. Tetrahedron 1991, 47, 2065.
26. Hakomori, S. Handbook of Lipid Research, Vol. 3, Sphingolipid Biochemistry; Kanfer, J. N.; Hakomori, S., Eds.; Plenum Press: New York, 1983; p. 6.
27. (a) Kozikowski, A. P.; Wu, J.-P. Tetrahedron Lett. 1990, 31, 4309.
28. (b) Byun, H.; Erukulla, R. K.; Bittman, R. J. Org. Chem. 1994, 59, 6495.
29. (a) Li, S.; Wilson, W. K.; Schroepfer Jr., G. J. J. Lipid Research 1999, 40, 117.
30. (b) Herdewijin, P.; De Jonghe, S.; Van Overmeire, I.; Gunst, J.; De Brunyn, A.; Hendrix, C.; Van Calenbergh, S.; Busson, R.; De Keukeleire, D.; Phillipe, J. Bioorg. Med. Chem. Lett. 1999, 9, 3159, 3175.
31. (c) Kokotos, G. Pardrón, J. M.; Martin, V. S.; Hadjipavlou-Litina, D.; Noula, C.; Constantinou-Kokotou, V.; Peters, G. J. Bioorg. Med. Chem. Lett. 1999, 9, 821.
32. (d) Murakami, T.; Taguchi, K. Tetrahedron, 1999, 55, 989.
33. (e) He, L.; Byun, H.-P.; Smit, J.; Wilschut, J.; Bittman, R. J. Am. Chem. Soc. 1999, 121, 3897.
34. (f) Ruan, F.; Yamamura, S.; Hakomori, S.; Igarashi, Y. Tetrahedron Lett. 1995, 36, 6615.
35. 3 solution. The enantiomeric purity (ee) was determined later from its derivative because 10 is readily converted into the corresponding α,β-epoxy ester under basic conditions. The absolute configuration was assumed from the results in Ref. 4 and confirmed later by comparison of the optical rotation with that reported for the final product, acetyl (D)-threo-sphingosine.
36. 1H NMR analysis at 500 MHz. There was no detectable amount of the other enantiomer.
37. Tkaczuk, P.; Thornton, E. R. J. Org. Chem. 1981, 46, 4393.
38. This research was assisted financially by a grant from the National Institutes of Health.